Rapid Micro BiosystemsRPID
RPID
About: Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
Employees: 163
0
Funds holding %
of 7,433 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
29% more capital invested
Capital invested by funds: $40.4M [Q1] → $52.1M (+$11.6M) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q1] → 2 (+0) [Q2]
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
1.16% less ownership
Funds ownership: 39.53% [Q1] → 38.37% (-1.16%) [Q2]
4% less funds holding
Funds holding: 28 [Q1] → 27 (-1) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$8
207%
upside
Avg. target
$8
207%
upside
High target
$8
207%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
Lake Street Thomas Flaten | 207%upside $8 | Buy Initiated | 28 Jul 2025 |
Financial journalist opinion
Based on 5 articles about RPID published over the past 30 days
Negative
Zacks Investment Research
1 week ago
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.29 per share a year ago.
Neutral
Seeking Alpha
2 weeks ago
Rapid Micro Biosystems, Inc. (RPID) Q2 2025 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Michael Beaulieu - Vice President of Investor Relations & Corporate Communications Robert G. Spignesi - CEO, President & Director Sean M.
Neutral
GlobeNewsWire
2 weeks ago
Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results
LEXINGTON, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the second quarter ended June 30, 2025.
Neutral
GlobeNewsWire
2 weeks ago
Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.
LEXINGTON, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that it has entered into a five-year, $45 million term loan facility with Trinity Capital Inc. (Nasdaq: TRIN) (“Trinity Capital”).
Neutral
GlobeNewsWire
3 weeks ago
Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025
LEXINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2025 financial results prior to the market open on Tuesday, August 12, 2025.
Positive
Seeking Alpha
1 month ago
Rapid Micro Biosystems: Benefiting From Partnership With Merck; Initiating With 'Buy'
Initiating Rapid Micro Biosystems at 'buy' with $4.60 fair value, driven by strong growth potential in automated microbial quality control market. Growth Direct platform offers clear advantages over manual MQC, with automation, regulatory benefits, and a $10B addressable market opportunity. Merck partnership is a key catalyst, enabling global distribution, supply chain optimization, and improved gross margins for Rapid Micro Biosystems.
Neutral
GlobeNewsWire
2 months ago
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LEXINGTON, Mass., June 13, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grants on June 2, 2025, of (i) 160,000 restricted stock units (“RSUs”) of the Company's Class A common stock (“Common Stock”) and (ii) non-qualified stock options to purchase an aggregate of 250,000 shares of Common Stock (the “Options”) as a material inducement to employment to a new employee. All such equity awards were made under the Company's Inducement Plan, as amended (the “Inducement Plan”) and were approved by a majority of the independent directors of the Board of Directors or a duly authorized committee thereof in accordance with Nasdaq Listing Rule 5635(c)(4). The equity awards are subject to the terms and conditions of the Inducement Plan, and the terms and conditions of the applicable stock option and RSU award agreements covering the grants.
Neutral
GlobeNewsWire
3 months ago
Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors
LEXINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, is pleased to welcome Dr. Dafni Bika to the Company's Board of Directors (the “Board”).
Neutral
Seeking Alpha
3 months ago
Rapid Micro Biosystems, Inc. (RPID) Q1 2025 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Mike Beaulieu - VP, IR and Corporate Communications Rob Spignesi - President and CEO Sean Wirtjes - CFO Conference Call Participants Dan Arias - Stifel Paul Knight - KeyBanc Capital Markets Chad Wiatrowski - TD Cowen Operator Thank you for standing by. My name is RG, and I will be your conference operator today.
Negative
Zacks Investment Research
3 months ago
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.31 per share a year ago.
Charts implemented using Lightweight Charts™